# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000886163-23-000020
Filing Date
2023-04-20
Accepted
2023-04-20 16:08:18
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | lgnd_10-kxprintxcleanv2.pdf | ARS | 883022
| Complete submission text file | 0000886163-23-000020.txt |  | 1217529

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33093 | Film No.: 23833186
SIC: 2834 Pharmaceutical Preparations